Kinetic topographical heterogeneity in follicular thyroid neoplasms and growth patterns [6]

Histopathology

Volumn 51, Issue 3, 2007, Pages 416-418

  Diaz Cano, S J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 2;

ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; APOPTOSIS; CANCER INVASION; CELL HETEROGENEITY; CELL PROLIFERATION; CORRELATION COEFFICIENT; DOWN REGULATION; GENE MUTATION; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THYROID FOLLICULAR CARCINOMA; THYROID TUMOR; TUMOR CELL; TUMOR GROWTH; UPREGULATION;

ADENOCARCINOMA, FOLLICULAR; APOPTOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; KINETICS; THYROID GLAND; THYROID NEOPLASMS;

EID: 34548125440     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02778.x     Document Type: Letter

References (13)

1. Mar KC, Eimoto T, Nagaya S, Tateyama H. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 2006 48 801 807.
2. Lloyd R, DeLellis R, Heitz P, Eng C. Pathology and genetics of tumours of endocrine organs. Geneva : WHO Press 2004.
3. Diaz-Cano SJ, Blanes A, Rubio J, Matilla A, Wolfe HJ. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab. Invest. 2000 80 279 289.
4. Blanes A, Rubio J, Martinez A, Wolfe HJ, Diaz-Cano SJ. Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. Am. J. Clin. Pathol. 2002 118 93 100.
5. Blanes A, Sanchez-Carrillo JJ, Diaz-Cano SJ. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair. J. Clin. Endocrinol. Metab. 2006 91 1150 1158.
6. Diaz-Cano SJ. Adrenal medullary proliferation and clonality. In : 87th Annual Meeting of the US and Canadian Academy of Pathology; 28 February to 6 March 1998; Boston, MA, USA. 1998.
7. Diaz-Cano SJ, Blanes A, Wolfe HJ. PCR techniques for clonality assays. Diagn. Mol. Pathol. 2001 10 24 33.
8. Diaz-Cano SJ. Designing a molecular analysis of clonality in tumours. J. Pathol. 2000 191 343 344.
9. Diaz-Cano SJ. Clonality studies in the analysis of adrenal medullary proliferations. Application principles and limitations. Endocr. Pathol. 1998 9 301 316.
10. Diaz-Cano SJ. MAP kinase common pathway in thyroid carcinomas of follicular differentiation. J. Pathol. 2006 209 298 306.
11. Pomerance M, Quillard J, Chantoux F, Young J, Blondeau JP. High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms. J. Pathol. 2006 209 298 306.
12. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ. Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex. Am. J. Pathol. 2000 156 311 319.
13. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates. J. Pathol. 2000 192 221 228.